TRIOBP and myeloid sarcoma: In this study, WES has revealed that the frequency of the rare variant in TRIOBP is significantly different between the MS patients and healthy controls, and its allele frequency is much higher than that of reference in known databases (18.75 vs. 0.047% in ExAC).